M. Maciá

989 total citations
37 papers, 688 citations indexed

About

M. Maciá is a scholar working on Endocrinology, Diabetes and Metabolism, Pediatrics, Perinatology and Child Health and Immunology. According to data from OpenAlex, M. Maciá has authored 37 papers receiving a total of 688 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Pediatrics, Perinatology and Child Health and 7 papers in Immunology. Recurrent topics in M. Maciá's work include Pharmacovigilance and Adverse Drug Reactions (5 papers), Pharmaceutical studies and practices (4 papers) and Blood Pressure and Hypertension Studies (3 papers). M. Maciá is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (5 papers), Pharmaceutical studies and practices (4 papers) and Blood Pressure and Hypertension Studies (3 papers). M. Maciá collaborates with scholars based in Spain, Japan and Netherlands. M. Maciá's co-authors include Francisco J. de Abajo, Belén Oliva, Verónica Bryant, Bharat Thakrar, Román Pérez-Fernández, Jim Slattery, A Wisniewski, Tomás García‐Caballero, Samuel Seoane and M. Hernández‐Mayoral and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Infectious Diseases and Annals of the Rheumatic Diseases.

In The Last Decade

M. Maciá

36 papers receiving 671 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Maciá Spain 15 145 136 117 102 76 37 688
Gaël Le Roux France 13 76 0.5× 52 0.4× 62 0.5× 50 0.5× 91 1.2× 74 717
Eva Montané Spain 14 147 1.0× 79 0.6× 89 0.8× 11 0.1× 71 0.9× 40 746
Stefan Weiler Switzerland 15 228 1.6× 24 0.2× 62 0.5× 42 0.4× 87 1.1× 71 784
M. A. Mangues Spain 20 92 0.6× 17 0.1× 102 0.9× 53 0.5× 226 3.0× 49 1.0k
Michael Mosteller United States 18 202 1.4× 75 0.6× 79 0.7× 89 0.9× 164 2.2× 34 1.9k
Omar I. Saadah Saudi Arabia 18 338 2.3× 55 0.4× 333 2.8× 26 0.3× 147 1.9× 115 1.0k
Elina Jerschow United States 16 62 0.4× 92 0.7× 184 1.6× 13 0.1× 54 0.7× 70 1.5k
Jeong‐Hee Choi South Korea 21 121 0.8× 35 0.3× 130 1.1× 11 0.1× 161 2.1× 91 1.2k
Odelya E. Pagovich United States 15 71 0.5× 25 0.2× 36 0.3× 24 0.2× 194 2.6× 25 861
R Hoigné Switzerland 16 127 0.9× 115 0.8× 62 0.5× 14 0.1× 42 0.6× 89 969

Countries citing papers authored by M. Maciá

Since Specialization
Citations

This map shows the geographic impact of M. Maciá's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Maciá with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Maciá more than expected).

Fields of papers citing papers by M. Maciá

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Maciá. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Maciá. The network helps show where M. Maciá may publish in the future.

Co-authorship network of co-authors of M. Maciá

This figure shows the co-authorship network connecting the top 25 collaborators of M. Maciá. A scholar is included among the top collaborators of M. Maciá based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Maciá. M. Maciá is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maciá, M., et al.. (2024). Risk of agranulocytosis with metamizole in comparison with alternative medications based on health records in Spain. European Journal of Clinical Pharmacology. 80(10). 1503–1514. 2 indexed citations
2.
Agustí, Antònia, et al.. (2023). Clinical pharmacology facing the real-world setting: Pharmacovigilance, pharmacoepidemiology and the economic evaluation of drugs. Pharmacological Research. 197. 106967–106967. 9 indexed citations
3.
Plueschke, Kelly, Robert Flynn, Karin Hedenmalm, et al.. (2022). Prescribing Patterns of Codeine and Alternative Medicines in Children in Europe. Drug Safety. 45(10). 1069–1081. 4 indexed citations
4.
Hedenmalm, Karin, Kevin Blake, Katherine Donegan, et al.. (2019). A European multicentre drug utilisation study of the impact of regulatory measures on prescribing of codeine for pain in children. Pharmacoepidemiology and Drug Safety. 28(8). 1086–1096. 14 indexed citations
5.
Vries, Sieta T. de, et al.. (2018). Safety Communication Tools and Healthcare Professionals’ Awareness of Specific Drug Safety Issues in Europe: A Survey Study. Drug Safety. 41(7). 713–724. 18 indexed citations
6.
Wisniewski, A, Andrew Bate, Cédric Bousquet, et al.. (2016). Good Signal Detection Practices: Evidence from IMI PROTECT. Drug Safety. 39(6). 469–490. 106 indexed citations
7.
Bermúdez, María A., Juan Sendón-Lago, Noemí Eiró, et al.. (2015). Corneal Epithelial Wound Healing and Bactericidal Effect of Conditioned Medium From Human Uterine Cervical Stem Cells. Investigative Ophthalmology & Visual Science. 56(2). 983–992. 77 indexed citations
8.
9.
Maciá, M.. (2015). Evaluación económica de la restricción del uso de piroxicam en España. Reumatología Clínica. 11(6). 345–352. 2 indexed citations
10.
Pérez-Fernández, Román, et al.. (2007). Vitamin D, Pit-1, GH, and PRL: Possible Roles in Breast Cancer Development. Current Medicinal Chemistry. 14(29). 3051–3058. 11 indexed citations
11.
12.
Gil, Carmen, et al.. (2005). Pit-1 is expressed in normal and tumorous human breast and regulates GH secretion and cell proliferation. European Journal of Endocrinology. 153(2). 335–344. 45 indexed citations
13.
Solera, Javier, Paloma Geijo, Manuel Rodríguez Zapata, et al.. (2004). A Randomized, Double-Blind Study to Assess the Optimal Duration of Doxycycline Treatment for Human Brucellosis. Clinical Infectious Diseases. 39(12). 1776–1782. 44 indexed citations
14.
15.
16.
Martínez, S., Javier Solera, M. Maciá, et al.. (2000). Evaluación de dos pautas de quimioprofilaxis tuberculosa en pacientes infectados por el virus de la inmunodeficiencia humana. Medicina Clínica. 115(5). 161–165. 27 indexed citations
17.
Hernández‐Mayoral, M. & M. Maciá. (1996). Free peripheral sulfhydryl groups, CD11/CD18 integrins, and calcium are required in the cadmium and nickel enhancement of human-polymorphonuclear leukocyte adherence. Archives of Environmental Contamination and Toxicology. 30(4). 437–443. 14 indexed citations
18.
Maciá, M., et al.. (1995). Modulation of the adherence of human polymorphonuclear leukocytes by cadmium and nickel: Sexual differences. Archives of Environmental Contamination and Toxicology. 29(1). 15–19. 7 indexed citations
19.
Hernández‐Mayoral, M., et al.. (1991). Cadmium and nickel modulation of adherence capacity of murine peritoneal macrophages and lymphocytes. Intersexual comparisons. International Journal of Biochemistry. 23(5-6). 541–544. 3 indexed citations
20.
Coronel, Francisco, et al.. (1991). Treatment of Hyperlipemia in Diabetic Patients on Dialysis with a Physiological Substance. American Journal of Nephrology. 11(1). 32–36. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gaël Le Roux Breakdown of academic impact, for papers by Eva Montané Breakdown of academic impact, for papers by Stefan Weiler Breakdown of academic impact, for papers by M. A. Mangues Breakdown of academic impact, for papers by Michael Mosteller Breakdown of academic impact, for papers by Omar I. Saadah Breakdown of academic impact, for papers by Elina Jerschow Breakdown of academic impact, for papers by Jeong‐Hee Choi Breakdown of academic impact, for papers by Odelya E. Pagovich Breakdown of academic impact, for papers by R Hoigné
Rankless by CCL
2026